Meeting
2013 ASCO Annual Meeting
Efficacy of radioimmunotherapy-based conditioning with high-dose chemotherapy and autologous stem cell transplantation for transformed lymphoma.
Authors
Amrita Y. Krishnan
City of Hope, Duarte, CA
Amrita Y. Krishnan , Marielle Wondergem , Joycelynne Palmer , Avichai Shimoni , Andrew Antony Raubitschek , Auayporn Nademanee , Otto Visser , Jose M Zijlstra , Nicole Tsai , Arnon Nagler , Neil Martin Kogut , Jennifer Simpson , Stephen J. Forman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lymphoma and Plasma Cell Disorders
Track
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Sub Track
Lymphoma
Citation
J Clin Oncol 31, 2013 (suppl; abstr 8556)
DOI
10.1200/jco.2013.31.15_suppl.8556
Abstract #
8556
Poster Bd #
48C
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
High-dose versus standard-dose rituximab with BEAM in autologous stem cell transplantation (SCT) for relapsed aggressive b-cell non-Hodgkin’s lymphomas (NHL).
First Author: Samer Ali Srour
Poster
2021 ASCO Annual Meeting
Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma.
First Author: Niloufer Khan
Poster
2020 ASCO Virtual Scientific Program
Role of high-dose chemotherapy with autologous stem cell transplantation for primary central nervous system lymphoma: A systematic review.
First Author: Shaha Nabeel
Poster
2011 ASCO Annual Meeting
Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation (ASCT) for Hodgkin lymphoma (HL).
First Author: B. M. William